Kumovis GmbH got its start at the Technical University of Munich by five alumni in fields ranging from medical technology to polymer engineering. In 2017, they co-founded the company focusing on 3D printing medical devices with high-performance and biodegradable polymers. Just two years later, in 2019, Kumovis released the R1 3D printer introducing a system for decentralized clean room production to the medtech market.
company delivers a range of products and services, including 3D printer installations, remote support, on-site trainings and product design, among others. Kumovis enables organizations to 3D print small batches and individualizations of medical devices with filaments such as PEEK, PPSU and PLLA in a regulatory compliant, reproducible and resource-efficient way.
Optional closing words focusing on Kumovis stakeholders:
Investors like Renolit, Solvay Ventures and High-Tech Gruenderfonds are supporting Kumovis in achieving its purpose: to enable additive manufactured medical devices wherever healthcare workers need them. Now and in the future.